These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

50 related items for PubMed ID: 1755260

  • 1. [The effect of physical training on the pharmacokinetics of steroidal contraceptives].
    Klinger G, Seidel E, Carol W, Boer J, Pocha C.
    Zentralbl Gynakol; 1991; 113(22):1240-5. PubMed ID: 1755260
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of ethinylestradiol and levonorgestrel after administration of two oral contraceptive preparations.
    Carol W, Klinger G, Jäger R, Kasch R, Brandstädt A.
    Exp Clin Endocrinol; 1992; 99(1):12-7. PubMed ID: 1628691
    [Abstract] [Full Text] [Related]

  • 3. [Inter- and intra-individual variability of pharmacokinetic parameters for contraceptive steroids].
    Carol W, Klinger G, Jäger R, Kasch R, Michels W.
    Zentralbl Gynakol; 1991; 113(13):783-7. PubMed ID: 1927130
    [Abstract] [Full Text] [Related]

  • 4. [Pharmacokinetics of ethinyl estradiol following the administration of combination contraceptive preparations].
    Carol W, Klinger G, Jäger R, Kasch R.
    Zentralbl Gynakol; 1990; 112(3):135-41. PubMed ID: 2336888
    [Abstract] [Full Text] [Related]

  • 5. [Pharmacokinetics of contraceptive steroids with reference to long-term administration].
    Carol W, Klinger G, Michels W, Boer J, Pocha C.
    Zentralbl Gynakol; 1991; 113(23):1298-303. PubMed ID: 1796663
    [Abstract] [Full Text] [Related]

  • 6. A pharmacokinetic study with a low-dose oral contraceptive containing 20 microg ethinylestradiol plus 100 microg levonorgestrel.
    Endrikat J, Blode H, Gerlinger C, Rosenbaum P, Kuhnz W.
    Eur J Contracept Reprod Health Care; 2002 Jun; 7(2):79-90. PubMed ID: 12201326
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetic comparison of two triphasic oral contraceptive formulations containing levonorgestrel and ethinylestradiol.
    Stanczyk FZ, Lobo RA, Chiang ST, Woutersz TB.
    Contraception; 1990 Jan; 41(1):39-53. PubMed ID: 2105872
    [Abstract] [Full Text] [Related]

  • 8. Lack of effect of tenofovir disoproxil fumarate on pharmacokinetics of hormonal contraceptives.
    Kearney BP, Mathias A.
    Pharmacotherapy; 2009 Aug; 29(8):924-9. PubMed ID: 19637945
    [Abstract] [Full Text] [Related]

  • 9. The effects of rifampin and rifabutin on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive.
    Barditch-Crovo P, Trapnell CB, Ette E, Zacur HA, Coresh J, Rocco LE, Hendrix CW, Flexner C.
    Clin Pharmacol Ther; 1999 Apr; 65(4):428-38. PubMed ID: 10223781
    [Abstract] [Full Text] [Related]

  • 10. Antacid does not reduce the bioavailability of oral contraceptive steroids in women.
    Joshi JV, Sankolli GM, Shah RS, Joshi UM.
    Int J Clin Pharmacol Ther Toxicol; 1986 Apr; 24(4):192-5. PubMed ID: 3086241
    [Abstract] [Full Text] [Related]

  • 11. [Effect of the estrogen-progesterone combination preparations gravistat and Minisiston on carbohydrate metabolism].
    Albus C, Männchen E.
    Zentralbl Gynakol; 1987 Apr; 109(8):521-6. PubMed ID: 3111130
    [Abstract] [Full Text] [Related]

  • 12. Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women.
    Griffith SG, Dai Y.
    Clin Ther; 2004 Dec; 26(12):2056-65. PubMed ID: 15823769
    [Abstract] [Full Text] [Related]

  • 13. Effect of multiple-dose dexloxiglumide on the pharmacokinetics of oral contraceptives in healthy women.
    Roy P, Jakate AS, Patel A, Abramowitz W, Wangsa J, Persiani S, Kapil R.
    J Clin Pharmacol; 2005 Mar; 45(3):329-36. PubMed ID: 15703367
    [Abstract] [Full Text] [Related]

  • 14. Thalidomide does not alter the pharmacokinetics of ethinyl estradiol and norethindrone.
    Trapnell CB, Donahue SR, Collins JM, Flockhart DA, Thacker D, Abernethy DR.
    Clin Pharmacol Ther; 1998 Dec; 64(6):597-602. PubMed ID: 9871424
    [Abstract] [Full Text] [Related]

  • 15. Observations with Anteovin in relation to age.
    Szigethy A.
    Ther Hung; 1991 Dec; 39(1):11-5. PubMed ID: 1858069
    [Abstract] [Full Text] [Related]

  • 16. The relative bioavailability of levonorgestrel and ethinylestradiol when administered in tablet and capsule form.
    Back DJ, Killick SR, Stevenson PJ, Shenoy N, Elstein M, Cohen M.
    Contraception; 1987 Sep; 36(3):321-6. PubMed ID: 3119288
    [Abstract] [Full Text] [Related]

  • 17. Thalidomide does not alter estrogen-progesterone hormone single dose pharmacokinetics.
    Scheffler MR, Colburn W, Kook KA, Thomas SD.
    Clin Pharmacol Ther; 1999 May; 65(5):483-90. PubMed ID: 10340913
    [Abstract] [Full Text] [Related]

  • 18. The effect of low-oestrogen combined pill, progestogen-only pill and medroxyprogesterone acetate on oral glucose tolerance test.
    Kamau RK, Maina FW, Kigondu C, Mati JK.
    East Afr Med J; 1990 Aug; 67(8):550-5. PubMed ID: 2148146
    [Abstract] [Full Text] [Related]

  • 19. Comparative pharmacokinetics of levonorgestrel and ethinyloestradiol following intravenous, oral and vaginal administration.
    Back DJ, Grimmer SF, Rogers S, Stevenson PJ, Orme ML.
    Contraception; 1987 Oct; 36(4):471-9. PubMed ID: 3127114
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.